Single-dose pharmacokinetics of orally and rectally administered misoprostol in adult horses

被引:7
作者
Lopp, Christine T. [1 ,3 ]
McCoy, Annette M. [1 ]
Boothe, Dawn [2 ]
Schaeffer, David J. [1 ]
Lascola, Kara [2 ]
机构
[1] Univ Illinois, Dept Vet Clin Sci, Coll Vet Med, Urbana, IL 61802 USA
[2] Auburn Univ, Coll Vet Med, Dept Clin Sci, Auburn, AL 36849 USA
[3] Mississippi State Univ, Coll Vet Med, Dept Clin Sci, Mississippi State, MS 39762 USA
关键词
DRUG ABSORPTION; FREE ACID; RELEASE; BIOAVAILABILITY; PHENYLBUTAZONE; METRONIDAZOLE; DISPOSITION; PROFILES; KINETICS; PLASMA;
D O I
10.2460/ajvr.80.11.1026
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
OBJECTIVE To characterize the pharmacokinetics of a clinically relevant dose of misoprostol administered PO or per rectum (PR) to horses. ANIMALS 8 healthy adult horses. PROCEDURES In a randomized 3-way crossover design, horses received a single dose of misoprostol (5 mu g/kg) administered PO (with horses fed and unfed) and PR, with a minimum 3-week washout period separating the experimental conditions. Blood samples were obtained before and at various points after drug administration (total, 24 hours), and plasma concentrations of misoprostol free acid were measured. RESULTS Mean maximum plasma concentration of misoprostol was significantly higher in the PR condition (mean +/- SD, 967 +/- 492 pg/mL) and unfed PO condition (655 +/- 259 pg/mL) than in the fed PO condition (352 +/- 109 pg/mL). Mean area under the concentration-versus-time curve was significantly lower in the PR condition (219 +/- 131 pg.h/mL) than in the unfed (1,072 +/- 360 pg.h/mL) and fed (518 +/- 301 pg.h/mL) PO conditions. Mean time to maximum concentration was <= 30 minutes for all conditions. Mean disappearance half-life was shortest in the PR condition (21 +/- 29 minutes), compared with values for the unfed (170 +/- 129 minutes) and fed (119 +/- 51 minutes) PO conditions. No adverse effects were noted. CONCLUSIONS AND CLINICAL RELEVANCE Misoprostol was rapidly absorbed and eliminated regardless of whether administered PO or PR to horses. Rectal administration may be a viable alternative for horses that cannot receive misoprostol PO, but this route may require more frequent administration to maintain therapeutic drug concentrations.
引用
收藏
页码:1026 / 1033
页数:8
相关论文
共 52 条
[21]  
FDA, 2009, CYT MIS TABL
[22]   Pharmacokinetics of a novel oral slow-release form of misoprostol [J].
Fiala, C ;
Aronsson, A ;
Granath, F ;
Stephansson, O ;
Seyberth, HW ;
Watzer, B ;
Gemzell-Danielsson, K .
HUMAN REPRODUCTION, 2005, 20 (12) :3414-3418
[23]   DISPOSITION OF MISOPROSTOL AND ITS ACTIVE METABOLITE IN PATIENTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION [J].
FOOTE, EF ;
LEE, DR ;
KARIM, A ;
KEANE, WF ;
HALSTENSON, CE .
JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (04) :384-389
[24]   Misoprostol modulates cytokine expression through a cAMP pathway: Potential therapeutic implication for liver disease [J].
Gobejishvili, Leila ;
Ghare, Smita ;
Khan, Rehan ;
Cambon, Alexander ;
Barker, David F. ;
Barve, Shirish ;
McClain, Craig ;
Hill, Daniell .
CLINICAL IMMUNOLOGY, 2015, 161 (02) :291-299
[25]   Drug therapy: Misoprostol and pregnancy. [J].
Goldberg, AB ;
Greenberg, MB ;
Darney, PD .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (01) :38-47
[26]   Mid-gestation pregnancy is not disrupted by a 5-day gastrointestinal mucosal cytoprotectant oral regimen of misoprostol [J].
Jacobson, C. C. ;
Sertich, P. L. ;
McDonnell, S. M. .
EQUINE VETERINARY JOURNAL, 2013, 45 (01) :91-93
[27]   Oral, rectal, and vaginal pharmacokinetics of misoprostol [J].
Khan, RU ;
El-Refaey, H ;
Sharma, S ;
Sooranna, D ;
Stafford, M .
OBSTETRICS AND GYNECOLOGY, 2004, 103 (05) :866-870
[28]   The effect of nonsteroidal anti-inflammatory drugs on the equine intestine [J].
Marshall, J. F. ;
Blikslager, A. T. .
EQUINE VETERINARY JOURNAL, 2011, 43 :140-144
[29]   Pharmacokinetics and ex vivo anti-inflammatory effects of oral misoprostol in horses [J].
Martin, E. M. ;
Schirmer, J. M. ;
Jones, S. L. ;
Davis, J. L. .
EQUINE VETERINARY JOURNAL, 2019, 51 (03) :415-421
[30]   Misoprostol Inhibits Lipopolysaccharide-Induced Pro-inflammatory Cytokine Production by Equine Leukocytes [J].
Martin, Emily Medlin ;
Messenger, Kristen M. ;
Sheats, Mary Katherine ;
Jones, Samuel L. .
FRONTIERS IN VETERINARY SCIENCE, 2017, 4